BioSpace News Archive

Press Releases

CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024

October 31, 2024
·
2 min read
Press Releases

Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024

October 31, 2024
·
1 min read
Press Releases

Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Announce the First Patient Dosed in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 / SAKK 66/22)

October 31, 2024
·
11 min read
Press Releases

Genprex to Participate in 2024 BIO Europe Conference

October 31, 2024
·
5 min read
Press Releases

Pediatric Neurology Organizations Partner, Receive Funding to Build Registry for Neonatal Hypoxic Ischemic Encephalopathy

October 31, 2024
·
3 min read
Press Releases

Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets

October 31, 2024
·
1 min read
Press Releases

Avantect Pancreatic Cancer Test Cost-Effective When Used as a Surveillance Tool in High-Risk Patients Newly Diagnosed with Diabetes

October 31, 2024
·
2 min read
Press Releases

Solid Biosciences to Participate at the Truist Securities BioPharma Symposium

October 31, 2024
·
1 min read
Press Releases

Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement

October 31, 2024
·
8 min read
Press Releases

Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results on November 7th, 2024 at 4:30 p.m. ET

October 31, 2024
·
5 min read